Cord Blood America, Inc. Reports Earnings Results for the Fourth Quarter and Year Ended December 31, 2017
April 02, 2018 at 08:00 am EDT
Share
Cord Blood America, Inc. reported earnings results for the fourth quarter and year ended December 31, 2017. For the quarter, total revenue from discontinued operations was $0.75 million, an increase of $0.02 million or 2.8% from $0.73 million in fourth quarter 2016. Net loss from continuing operations was $0.34 million compared to $0.31 million for the three-month period ended December 31, 2016.
For the year, total revenue from discontinued operations was $2.99 million, a decrease of $0.29 million or 8.9% from $3.29 million in fiscal 2016. Net loss from continuing operations was $1.62 million compared to net loss of $1.92 million for fiscal 2016.
CBA Florida, Inc., formerly Cord Blood America, Inc., through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. The Company's subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. The Company and its subsidiaries provides private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord's operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.
CBA FLORIDA, INC.